Torrent Pharmaceuticals (TORNTPHARM) — Board Meeting

📢 Key Event
Appointment of Shanti Ekambaram as Additional Independent Director

💡 Investor Takeaway
Her finance and governance expertise may enhance board oversight and strategic direction.

Torrent Pharmaceuticals announced the appointment of Shanti Ekambaram as an Additional Independent Director effective 30 July 2026 for a three-year term, pending shareholder approval. She brings 39 years of banking and governance experience, including leadership roles at Kotak Mahindra Bank and CEO of Kotak Mahindra Capital, with a track record in capital markets innovation and ESG. Her appointment strengthens board expertise in finance and strategy.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TORNTPHARM ✨ Ask AI About This

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

💡 Ask AI about this filing

"How will Ekambaram's banking background influence Torrent's capital allocation strategy?" "What shareholder approval process is required for the director appointment?" "How does her ESG experience align with Torrent's current sustainability initiatives?"

Ask AI Free →

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

🔥 Also filed on 28 July 2026

LT Larsen & Toubro Limited Corporate Action TI Tilaknagar Industries Limited Financial Results LGBBROSLTD LG Balakrishnan & Bros Limited Announcement MAXIND Max India Limited Annual Report RVNL Rail Vikas Nigam Limited Corporate Action NIRAJ Niraj Cement Structurals Limited Offer Document

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.